ROCS (Radiotherapy After Oesophageal Cancer Stenting) Study

PHASE3CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Oesophageal Cancer
Interventions
RADIATION

Radiotherapy

External beam radiotherapy (EBRT) delivering a tumour absorbed dose of 20Gy in 5 fractions or 30Gy in 10 fractions.

Trial Locations (17)

BS2 8ED

Bristol Haematology and Oncology Centre, Bristol

DN2 5LT

Doncaster Royal Infirmary, Doncaster

TS4 3BW

James Cook University Hospital, Middlesbrough

CV10 7DJ

George Eliot Hospital, Nuneaton

TN37 7RD

Conquest Hospital, Saint Leonards-on-Sea

S1O 2SJ

Cancer Research Centre at Weston Park Hospital, Sheffield

TA1 5DA

Musgrove Park Hospital, Taunton

SS0 0RY

Southend University Hospital NHS Foundation Trust, Westcliff-on-Sea

BS23 4TQ

Weston General Hospital, Weston-super-Mare

DD1 9SY

Ninewells Hospital, Dundee

LL57 2PW

Ysbyty Gwynedd, Bangor

CF14 2TL

Velindre Cancer Center at Velindre Hospital, Cardiff

NP9 2UB

Royal Gwent Hospital, Newport Gwent

LL 18 5UJ

Glan Clwyd Hospital, Rhyl, Denbighshire

LL13 7TD

Wrexham Maelor Hospital, Wrexham

Unknown

Weston Park Hospital, Sheffield

Southampton General Hospital, Southampton

All Listed Sponsors
lead

Lisette Nixon

OTHER_GOV

NCT01915693 - ROCS (Radiotherapy After Oesophageal Cancer Stenting) Study | Biotech Hunter | Biotech Hunter